A Phase 1 study of BF844 in healthy volunteers
Not Yet Recruiting Phase 1 NCT06592131
Study Description
A clinical trial to evaluate the safety, tolerability, and pharmacokinetics of BF844, a novel investigational drug, in healthy adult participants
Study Details
- Registry ID:
- NCT06592131
- Conditions:
- Usher Syndrome Type 3
- Phase:
- Phase 1
- Target Enrollment:
- 76 participants
- Start Date:
- Healthy Volunteers:
- No
Study Locations (1 site)
-
Linear Clinical Research
Perth, Australia
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.